DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Nicergoline

Nicergoline

  • Inline-Supplementary-Material-1.Pdf

    Inline-Supplementary-Material-1.Pdf

  • PDF Download

    PDF Download

  • Local Product Document Pfizer Venezuela, S.A

    Local Product Document Pfizer Venezuela, S.A

  • Nicergoline

    Nicergoline

  • Non-Antibiotics, Efflux Pumps and Drug Resistance of Gram-Negative Rods

    Non-Antibiotics, Efflux Pumps and Drug Resistance of Gram-Negative Rods

  • 4 Supplementary File

    4 Supplementary File

  • Safety of Nicergoline As an Agent for Management of Cognitive Function Disorders

    Safety of Nicergoline As an Agent for Management of Cognitive Function Disorders

  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

    Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

  • Ergot Derivatives Art. 31

    Ergot Derivatives Art. 31

  • A7471055 Treatment Access Protocol For

    A7471055 Treatment Access Protocol For

  • Ergot Alkaloids: a Review on Therapeutic Applications

    Ergot Alkaloids: a Review on Therapeutic Applications

  • Rilutek 109-R-12 Incl Final SPC&PL

    Rilutek 109-R-12 Incl Final SPC&PL

  • Data Sheet 1 Rilutek 50Mg Film Coated Tablets

    Data Sheet 1 Rilutek 50Mg Film Coated Tablets

  • A Systematic Review and Meta-Analysis Assessing Adverse Event Profile and Tolerability of Nicergoline

    A Systematic Review and Meta-Analysis Assessing Adverse Event Profile and Tolerability of Nicergoline

  • Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide

    Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide

  • Assessment Report on Ginkgo Biloba L., Folium

    Assessment Report on Ginkgo Biloba L., Folium

  • Management of PRURITUS in Patients with Chronic Kidney Disease

    Management of PRURITUS in Patients with Chronic Kidney Disease

  • Pharmacotherapy for Urinary Bladder Dysfunction in Spinal Cord Injury Patients

    Pharmacotherapy for Urinary Bladder Dysfunction in Spinal Cord Injury Patients

Top View
  • Pleuropulmonary Changes Induced by Ergoline Drugs
  • The Impact of Efflux Pump Inhibitors on the Activity of Selected Non
  • Practice Parameter: Management of Dementia (An Evidence-Based Review)
  • Practical Aspects of Drug Interactions in the Pharmacotherapy in Otolaryngology, Or the Seven Cardinal Sins of Pharmacological Treatment in Otolaryngological Practice
  • Drugs That May Injure the Respiratory System
  • Product List
  • Newsletterno5 2013EC.Pdf
  • Online Supplementary Etable1 Etable 1. Risk Medications/Classes
  • Safety of Nicergoline As an Agent for Management of Cognitive Function Disorders
  • Anti-Dementia Medications – Fighting a Losing Battle?
  • General Information
  • Potentially Inappropriate Medications in the Elderly: a French Consensus Panel List
  • A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
  • Nicergoline Containing Medicinal Products (See Annex I)
  • Differential Regulation of Human Serotonin Receptor Type 3A by Chanoclavine and Ergonovine
  • 210311 Wild Guided Report.Indd
  • Ameliorative Effect of Nicergoline on Cognitive Function Through the PI3K/AKT Signaling Pathway in Mouse Models of Alzheimer's Disease
  • Antidepressive Effect of Nicergoline on Patients with Mild Post-Stroke Depression


© 2024 Docslib.org    Feedback